Humana Inc. (HUM)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 218 |
| % of all portfolios: | 0.044% |
| Hold Price * : | $420.68 |
| History |
Portfolio Manager |
Activity ▼ |
Share change |
% change to portfolio |
| Q1 2024 |
| ≡ |
Richard Pzena - Hancock Classic Value |
Buy |
57,680 |
1.18 |
| Q4 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 53.10% |
82,423 |
0.78 |
| Q3 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 28.25% |
34,188 |
0.39 |
| Q2 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 12521.48% |
120,081 |
1.14 |
| ≡ |
Christopher Davis - Davis Advisors |
Add 0.05% |
21 |
0.00 |
| Q1 2023 |
| ≡ |
Christopher Davis - Davis Advisors |
Add 0.30% |
132 |
0.00 |
| Q2 2022 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 34.56% |
83,020 |
0.97 |
| Q4 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 0.87% |
2,191 |
0.01 |
| Q3 2021 |
| ≡ |
Viking Global Investors |
Add 411.17% |
2,418,848 |
2.62 |
| ≡ |
Bill Nygren - Oakmark Select Fund |
Add 47.32% |
150,000 |
1.17 |
| Q2 2021 |
| ≡ |
Viking Global Investors |
Buy |
588,285 |
0.79 |
| Q1 2021 |
| ≡ |
Christopher Davis - Davis Advisors |
Add 0.02% |
12 |
0.00 |
| ≡ |
Bill Nygren - Oakmark Select Fund |
Buy |
317,000 |
2.85 |
| Q4 2020 |
| ≡ |
Christopher Davis - Davis Advisors |
Add 1.18% |
742 |
0.00 |
| Q2 2020 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Add 12.01% |
259,953 |
0.52 |
| Q1 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 101.99% |
475,055 |
3.15 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Add 46.94% |
691,296 |
1.32 |
| Q4 2019 |
| ≡ |
Viking Global Investors |
Buy |
103,638 |
0.18 |
| Q3 2019 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
1,588,743 |
2.39 |
| Q2 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 150.95% |
932,778 |
3.59 |
| ≡ |
David Tepper - Appaloosa Management |
Buy |
95,391 |
1.13 |
| Q1 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
617,948 |
2.18 |
| Q2 2018 |
| ≡ |
Leon Cooperman |
Add 38.82% |
51,800 |
0.54 |
| Q1 2018 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 23.98% |
8,730 |
0.03 |
| Q4 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 71.75% |
15,210 |
0.05 |
| ≡ |
Leon Cooperman |
Buy |
171,353 |
1.61 |
| Q3 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 27.63% |
4,590 |
0.02 |
| Q2 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
16,610 |
0.05 |
| Q1 2017 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
1,184,119 |
1.28 |
| ≡ |
Leon Cooperman |
Buy |
125,000 |
1.04 |
| Q4 2016 |
| ≡ |
Daniel Loeb - Third Point |
Add 71.43% |
1,000,000 |
2.00 |
| Q3 2016 |
| ≡ |
Daniel Loeb - Third Point |
Buy |
1,400,000 |
2.15 |
| Q1 2016 |
| ≡ |
David Einhorn - Greenlight Capital |
Add 6.75% |
24,300 |
0.08 |
| Q4 2015 |
| ≡ |
David Einhorn - Greenlight Capital |
Buy |
360,000 |
1.20 |
| Q1 2015 |
| ≡ |
Leon Cooperman |
Buy |
593,400 |
1.72 |
| Q3 2014 |
| ≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
2,174,122 |
1.13 |
| Q2 2014 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
771,168 |
1.55 |
| Q4 2013 |
| ≡ |
Meridian Contrarian Fund |
Add 10.42% |
14,000 |
0.19 |
| Q3 2013 |
| ≡ |
Meridian Contrarian Fund |
Add 13.52% |
16,000 |
0.21 |
| Q2 2013 |
| ≡ |
Meridian Contrarian Fund |
Add 115.09% |
63,300 |
0.80 |
| Q1 2013 |
| ≡ |
Meridian Contrarian Fund |
Buy |
55,000 |
0.57 |
| Q2 2012 |
| ≡ |
David Einhorn - Greenlight Capital |
Buy |
1,645,000 |
2.15 |
| Q4 2009 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Add 23.86% |
2,623,900 |
1.41 |
| Q3 2009 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Add 41.10% |
3,203,600 |
1.58 |
| Q2 2009 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Add 8.89% |
636,300 |
0.33 |
| Q4 2008 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Buy |
7,563,500 |
4.34 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.